Access

Letter

Nature Cell Biology 10, 740–747 (1 June 2008) | doi:10.1038/ncb1737

An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway

Scott W. Rowlinson , Hideo Yoshizato , Johanna L. Barclay , Andrew J. Brooks , Stuart N. Behncken , Linda M. Kerr , Kirstin Millard , Kathryn Palethorpe , Katherine Nielsen , Jodie Clyde-Smith , John F. Hancock & Michael J. Waters

The growth and metabolic actions of growth hormone (GH) are believed to be mediated through the GH receptor (GHR) by JAK2 activation. The GHR exists as a constitutive homodimer, with signal transduction by ligand-induced realignment of receptor subunits.